✦ LIBER ✦

Vorinostat in combination with bortezomib in patients with advanced malignancies directly alters transcription of target genes

✍ Scribed by Jill M. Kolesar, Anne M. Traynor, Kyle D. Holen…

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I study of vorinostat in combina

✍ Schelman, William R.; Traynor, Anne M.; Holen, Kyle D.; Kolesar, Jill M.; Attia, 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 153 KB

Phase 1 study of sorafenib in combinatio

✍ Shaji K. Kumar, James Jett, Randolph Marks, Ronald Richardson, Fernando Quevedo, 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 191 KB

Phase I study of tanespimycin in combina

✍ Schenk, Erin; Hendrickson, Andrea E. Wahner; Northfelt, Donald; Toft, David O.; 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 144 KB

A Phase I study of intermittently dosed

✍ Deming, Dustin A.; Ninan, Jacob; Bailey, Howard H.; Kolesar, Jill M.; Eickhoff, 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 151 KB

Age-stratified phase I trial of a combin

✍ G. S. Falchook; M. Duvic; D. S. Hong; J. Wheler; A. Naing; J. Lim; R. Kurzrock 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 507 KB

A phase I pharmacodynamic trial of borte

✍ Noelle K. LoConte; James P. Thomas; Dona Alberti; Jennifer Heideman; Kimberly Bi 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 326 KB